|
MaxitrolDrug - Maxitrol The trade name of the product as shown on the labeling.
Dosage -
SUSPENSION/DROPS; OPHTHALMIC
Active Ingredient(s) -
Dexamethasone; Neomycin Sulfate; Polymyxin B Sulfate
Strength -
0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
Applicant -
FALCON PHARMS
New Drug Application (NDA) Number -
050023
Product Number -
002
Therapeutic Equivalence (TE) Code -
AT
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Falcon Pharmaceuticals Ltd
Maxitrol
Neomycin And Polymyxin B Sulfates And Dexamethasone 0.1%;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic
Dexacidin 0.1%;eq 3.5mg Base/ml;10,000 Units/ml Suspension/drops; Ophthalmic Dexasporin 0.1%;eq 3.5mg Base/ml;10,000 Units/ml Suspension/drops; Ophthalmic Dexasporin 0.1%;eq 3.5mg Base/ml;10,000 Units/ml Suspension/drops; Ophthalmic Maxitrol 0.1%;eq 3.5mg Base/ml;10,000 Units/ml Suspension/drops; Ophthalmic Maxitrol 0.1%;eq 3.5mg Base/ml;10,000 Units/ml Suspension/drops; Ophthalmic Dexacidin 0.1%;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic Dexasporin 0.1%;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic Maxitrol 0.1%;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic Neomycin And Polymyxin B Sulfates And Dexamethasone 0.1%;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic NewDrugInformation |